StockOttersSupply Chain Map

Emergent BioSolutions Inc.

EBS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue

1,044

Cost of Revenue

668

Gross Profit

375

Gross Margin

36.0%

Operating Income

-109

Operating Margin

-10.4%

Net Income

-191

Net Margin

-18.3%

EPS (Basic)

$-3.60

EPS (Diluted)

$-3.60

EBITDA

53

EBITDA Margin

5.1%

2023

12/31/2023

Revenue

1,049

Cost of Revenue

689

Gross Profit

360

Gross Margin

34.3%

Operating Income

-726

Operating Margin

-69.2%

Net Income

-761

Net Margin

-72.5%

EPS (Basic)

$-14.85

EPS (Diluted)

$-14.85

EBITDA

-47

EBITDA Margin

-4.5%

2022

12/31/2022

Revenue

1,118

Cost of Revenue

645

Gross Profit

473

Gross Margin

42.3%

Operating Income

-170

Operating Margin

-15.2%

Net Income

-212

Net Margin

-18.9%

EPS (Basic)

$-4.47

EPS (Diluted)

$-4.47

EBITDA

16

EBITDA Margin

1.4%

2021

12/31/2021

Revenue

1,774

Cost of Revenue

980

Gross Profit

793

Gross Margin

44.7%

Operating Income

341

Operating Margin

19.2%

Net Income

220

Net Margin

12.4%

EPS (Basic)

$4.10

EPS (Diluted)

$4.06

EBITDA

504

EBITDA Margin

28.4%

2020

12/31/2020

Revenue

1,577

Cost of Revenue

714

Gross Profit

863

Gross Margin

54.7%

Operating Income

439

Operating Margin

27.8%

Net Income

306

Net Margin

19.4%

EPS (Basic)

$5.79

EPS (Diluted)

$5.67

EBITDA

609

EBITDA Margin

38.6%

Income Statement (Annual)

Financial performance (amounts in millions)

Item	2024	2023	2022	2021	2020
Revenue	1,044	1,049	1,118	1,774	1,577
Cost of Revenue	668	689	645	980	714
Gross Profit	375	360	473	793	863
Gross Margin	36.0%	34.3%	42.3%	44.7%	54.7%
Operating Income	-109	-726	-170	341	439
Operating Margin	-10.4%	-69.2%	-15.2%	19.2%	27.8%
Net Income	-191	-761	-212	220	306
Net Margin	-18.3%	-72.5%	-18.9%	12.4%	19.4%
EPS (Basic)	$-3.60	$-14.85	$-4.47	$4.10	$5.79
EPS (Diluted)	$-3.60	$-14.85	$-4.47	$4.06	$5.67
EBITDA	53	-47	16	504	609
EBITDA Margin	5.1%	-4.5%	1.4%	28.4%	38.6%